99 related articles for article (PubMed ID: 19120397)
21. Trichomegaly induced by cetuximab.
Crespo-Carballes MJ; Garcia-Saenz MC; Gonzalez-Sosa ZC; Prieto-Del-Cura M
J Fr Ophtalmol; 2020 Nov; 43(9):958-960. PubMed ID: 32800413
[No Abstract] [Full Text] [Related]
22. Trichomegaly following treatment with gefitinib (ZD1839).
Pascual JC; Bañuls J; Belinchon I; Blanes M; Massuti B
Br J Dermatol; 2004 Nov; 151(5):1111-2. PubMed ID: 15541102
[No Abstract] [Full Text] [Related]
23. [Topical steroids in the treatment of paronychia induced by the epidermal growth factor receptor inhibitor cetuximab].
Coquart N; Karam A; Metges JP; Misery L
Ann Dermatol Venereol; 2010 Apr; 137(4):306-7. PubMed ID: 20417368
[No Abstract] [Full Text] [Related]
24. Manage infusion reactions from cetuximab.
Becze E
ONS Connect; 2008 Sep; 23(9):18-9. PubMed ID: 18807709
[No Abstract] [Full Text] [Related]
25. [Ipilimumab-induced poliosis].
Victoria Martínez AM; Estela Cubells JR; Cubells Sánchez L; Oliver Martínez V; Alegre de Miguel V
Med Clin (Barc); 2014 Mar; 142(5):234. PubMed ID: 24054775
[No Abstract] [Full Text] [Related]
26. Managing drug infusion reactions: focus on cetuximab monoclonal antibody therapy.
Wilkes G
Clin J Oncol Nurs; 2008 Jun; 12(3):530-2. PubMed ID: 18515254
[No Abstract] [Full Text] [Related]
27. Trichomegaly Induced by Cetuximab: Case Series and Review the Literature.
Koksal UI; Pilanci KN; Ordu C; Okutur K; Saglam S; Demir G
Am J Ther; 2016; 23(5):e1226-9. PubMed ID: 26079631
[TBL] [Abstract][Full Text] [Related]
28. Pimecrolimus: a novel treatment for cetuximab-induced papulopustular eruption.
Eiling E; Brandt M; Schwarz T; Hauschild A
Arch Dermatol; 2008 Sep; 144(9):1236-8. PubMed ID: 18794482
[No Abstract] [Full Text] [Related]
29. Behavioral disorders secondary to profound hypomagnesemia in a patient given cetuximab for metastatic colorectal cancer hypomagnesemia due to cetuximab treatment.
Perrin C; Fabre C; Raoul JL; Boucher E
Acta Oncol; 2006; 45(8):1135-6. PubMed ID: 17118852
[No Abstract] [Full Text] [Related]
30. Ocular toxicity related to cetuximab monotherapy in an advanced colorectal cancer patient.
Tonini G; Vincenzi B; Santini D; Olzi D; Lambiase A; Bonini S
J Natl Cancer Inst; 2005 Apr; 97(8):606-7. PubMed ID: 15840884
[No Abstract] [Full Text] [Related]
31. Neutrophilic eccrine hidradenitis induced by cetuximab.
Turan H; Kaya E; Gurlevik Z; Erdem H; Oktay M
Cutan Ocul Toxicol; 2012 Jun; 31(2):148-50. PubMed ID: 22034841
[TBL] [Abstract][Full Text] [Related]
32. Trichomegaly following treatment with interferon alpha-2b.
Hernández-Núñez A; Fernández-Herrera J; Buceta LR; García-Díez A
Lancet; 2002 Mar; 359(9312):1107. PubMed ID: 11943258
[No Abstract] [Full Text] [Related]
33. CALGB/SWOG C80405: A phase III trial of FOLFIRI or FOLFOX with bevacizumab or cetuximab or both for untreated metastatic adenocarcinoma of the colon or rectum.
Clin Adv Hematol Oncol; 2006 Jun; 4(6):452-3. PubMed ID: 16981668
[No Abstract] [Full Text] [Related]
34. [Acneiform eruptions induced by cetuximab].
Walon L; Gilbeau C; Lachapelle JM
Ann Dermatol Venereol; 2003 Apr; 130(4):443-6. PubMed ID: 12843857
[TBL] [Abstract][Full Text] [Related]
35. Eye complications of cetuximab therapy.
Melichar B; Nemcová I
Eur J Cancer Care (Engl); 2007 Sep; 16(5):439-43. PubMed ID: 17760931
[TBL] [Abstract][Full Text] [Related]
36. Trichomegaly of the eyelashes induced by the epidermal growth factor receptor inhibitor cetuximab in the treatment of metastatic colorectal cancer.
Matos LV; Pissarra A; Malheiro M; Plácido AN
BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 31040141
[No Abstract] [Full Text] [Related]
37. Poliosis associated with treatment of fungal endophthalmitis.
Watson AS; Giledi O; Daya SM
Orbit; 2004 Dec; 23(4):241-4. PubMed ID: 15590526
[TBL] [Abstract][Full Text] [Related]
38. [Cutaneous toxicity associated with cetuximab treatment in metastatic colorectal cancer].
Rodríguez-Murphy E; Villanueva-Herraiz S; Ortega-García MP; Pérez-Feliu A; López-Montenegro Soria MA; Camps-Herrero C
Farm Hosp; 2011; 35(3):114-20. PubMed ID: 21497124
[TBL] [Abstract][Full Text] [Related]
39. Invasive fungal infection and nasal septum perforation with bevacizumab-based therapy in advanced colon cancer.
Ruiz N; Fernandez-Martos C; Romero I; Pla A; Maiquez J; Calatrava A; Guillem V
J Clin Oncol; 2007 Aug; 25(22):3376-7. PubMed ID: 17664487
[No Abstract] [Full Text] [Related]
40. Fatal infusion reactions to cetuximab: role of immunoglobulin e-mediated anaphylaxis.
Pointreau Y; Commins SP; Calais G; Watier H; Platts-Mills TA
J Clin Oncol; 2012 Jan; 30(3):334; author reply 335. PubMed ID: 22162592
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
